| Human adult stem cells derived from adipose tissue protect against experimental colitis and sepsis E Gonzalez-Rey, P Anderson, MA González, L Rico, D Büscher, ... Gut 58 (7), 929-939, 2009 | 829 | 2009 |
| Adipose-derived mesenchymal stem cells alleviate experimental colitis by inhibiting inflammatory and autoimmune responses MA González, E Gonzalez–Rey, L Rico, D Büscher, M Delgado Gastroenterology 136 (3), 978-989, 2009 | 780 | 2009 |
| Treatment of experimental arthritis by inducing immune tolerance with human adipose‐derived mesenchymal stem cells MA González, E Gonzalez‐Rey, L Rico, D Büscher, M Delgado Arthritis & Rheumatism: Official Journal of the American College of …, 2009 | 651 | 2009 |
| Human adipose-derived mesenchymal stem cells reduce inflammatory and T cell responses and induce regulatory T cells in vitro in rheumatoid arthritis E Gonzalez-Rey, MA Gonzalez, N Varela, F O’Valle, P Hernandez-Cortes, ... Annals of the rheumatic diseases 69 (01), 241-248, 2010 | 537 | 2010 |
| The significance of vasoactive intestinal peptide in immunomodulation M Delgado, D Pozo, D Ganea Pharmacological reviews 56 (2), 249-290, 2004 | 529 | 2004 |
| Vasoactive intestinal peptide prevents experimental arthritis by downregulating both autoimmune and inflammatory components of the disease M Delgado, C Abad, C Martinez, J Leceta, RP Gomariz Nature medicine 7 (5), 563-568, 2001 | 455 | 2001 |
| Requirement of IFN-γ–mediated indoleamine 2, 3-dioxygenase expression in the modulation of lymphocyte proliferation by human adipose–derived stem cells O DelaRosa, E Lombardo, A Beraza, P Mancheno-Corvo, C Ramirez, ... Tissue Engineering Part A 15 (10), 2795-2806, 2009 | 360 | 2009 |
| Therapeutic action of ghrelin in a mouse model of colitis E Gonzalez–Rey, A Chorny, M Delgado Gastroenterology 130 (6), 1707-1720, 2006 | 323 | 2006 |
| Regulation of immune tolerance by anti-inflammatory neuropeptides E Gonzalez-Rey, A Chorny, M Delgado Nature Reviews Immunology 7 (1), 52-63, 2007 | 293 | 2007 |
| Therapeutic effects of vasoactive intestinal peptide in the trinitrobenzene sulfonic acid mice model of Crohn's disease C Abad, C Martinez, MG Juarranz, A Arranz, J Leceta, M Delgado, ... Gastroenterology 124 (4), 961-971, 2003 | 288 | 2003 |
| Adipose-derived mesenchymal stromal cells induce immunomodulatory macrophages which protect from experimental colitis and sepsis P Anderson, L Souza-Moreira, M Morell, M Caro, F O'Valle, ... Gut 62 (8), 1131-1141, 2013 | 244 | 2013 |
| Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide enhance IL-10 production by murine macrophages: in vitro and in vivo studies M Delgado, EJ Munoz-Elias, RP Gomariz, D Ganea The Journal of Immunology 162 (3), 1707-1716, 1999 | 235 | 1999 |
| Vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase-activation polypeptide (PACAP) protect mice from lethal endotoxemia through the inhibition of TNF-α and IL-6 M Delgado, C Martinez, D Pozo, JR Calvo, J Leceta, D Ganea, ... The Journal of Immunology 162 (2), 1200-1205, 1999 | 234 | 1999 |
| Neuroprotective effect of vasoactive intestinal peptide (VIP) in a mouse model of Parkinson's disease by blocking microglial activation M Delgado, D Ganea The FASEB journal 17 (8), 1-18, 2003 | 220 | 2003 |
| VIP and PACAP inhibit IL-12 production in LPS-stimulated macrophages. Subsequent effect on IFNγ synthesis by T cells M Delgado, EJ Munoz-Elias, RP Gomariz, D Ganea Journal of neuroimmunology 96 (2), 167-181, 1999 | 211 | 1999 |
| Vasoactive intestinal peptide generates human tolerogenic dendritic cells that induce CD4 and CD8 regulatory T cells E Gonzalez-Rey, A Chorny, A Fernandez-Martin, D Ganea, M Delgado Blood 107 (9), 3632-3638, 2006 | 209 | 2006 |
| Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit endotoxin-induced TNF-α production by macrophages: in vitro and in vivo studies M Delgado, D Pozo, C Martinez, J Leceta, JR Calvo, D Ganea, ... The Journal of Immunology 162 (4), 2358-2367, 1999 | 208 | 1999 |
| Immunology of VIP: a review and therapeutical perspectives RP Gomariz, C Martinez, C Abad, J Leceta, M Delgado Current pharmaceutical design 7 (2), 89-111, 2001 | 207 | 2001 |
| Vasoactive intestinal peptide in the immune system: potential therapeutic role in inflammatory and autoimmune diseases M Delgado, C Abad, C Martinez, M Juarranz, A Arranz, R Gomariz, ... Journal of molecular medicine 80, 16-24, 2002 | 205 | 2002 |
| Expression of the Mel1a‐melatonin receptor mRNA in T and B subsets of lymphocytes from rat thymus and spleen D Pozo, M Delgado, JM Fernandez‐Santos, JR Calvo, RP Gomariz, ... The FASEB journal 11 (6), 466-473, 1997 | 205 | 1997 |
Elena Gonzalez-ReyInstituto de Parasitología y Biomedicina López-Neyra-CSIC在 ipb.csic.es 的电子邮件经过验证
